App-Based diabetes coaching shows promise in small trial
NCT ID NCT07513961
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether a nurse-led mobile app could improve diabetes management in 112 adults with type 2 diabetes. The intervention group received structured education and reminders via the app for 6 months, while the control group got standard care. The main goal was to see if the app helped lower blood sugar levels (HbA1c) and improve self-care behaviors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Technology-Based Diabetes Education and Follow-up System (PAS-DM) - a mobile health platform providing structured education and reminders
What this could lead to
If successful, this approach could offer a scalable, low-cost way to help people with type 2 diabetes better manage their condition at home.
What could go wrong
This is a completed trial with 112 participants, so results are limited in size. The intervention requires a smartphone and internet, which may not be available to everyone. It focuses on education, not a new drug or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alanya Alaaddin Keykubat University Training and Research Hospital, Department of Internal Medicine
Alanya, Antalya, 07400, Turkey (Türkiye)